Assessing the Feasibility of Multi-modal Biosensing for Monitoring Mobility and Cognition in Older Adults
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Tufts University
- Study ID
- NCT07217951
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Chronic Stress
- Mobility and Independence
- Systemic Inflammation
Eligibility Criteria
- Sex
- ALL
- Age
- 65 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Eutectogel Sensors and Microneedle Patches — DEVICEEutectogel Sensors: While the exact eutectogel formulation in this study has not been previously tested in humans, similar eutectogel-based materials have been employed in wearable biosensing devices with human participants. These systems are typically composed of biocompatible matrices such as gelatin or polyacrylamide combined with deep eutectic solvents (DES) to improve ionic conductivity and flexibility. Microneedle Patches: The microneedle patch in this study is composed of poly(acrylic acid)/gelatin methacryloyl (PAA/GelMA), gelatin/oxidized pectin (Gelatin/OxP), and methacrylated hyaluronic acid/maleic anhydride (MeHA/MA). Although the integrated use of these specific compositions has not yet been evaluated in humans, the materials themselves, as well as similar microneedle architectures, have been thoroughly investigated in vivo and even in clinical trials.
Study Details
Current health devices often overlook older users, who may face both health challenges and technology barriers. We are investigating the feasibility of wearable sensors to track posture, heart rate, and breathing, alongside a microneedle patch that collect body fluids to measure stress and inflammation markers. By combining this data, we aim to create an easy to use system that supports personalized, at home health monitoring for older adults.
Key Dates
- Start date
- Dec 31, 2025
- Status verified
- Oct 2025
- Primary completion
- Sep 30, 2028
- Completion
- Sep 30, 2028
Study Design
- Enrollment
- 20 participants (estimated)
Arms
- Arm: Older adultsAdults aged 65 or older
Primary Outcome Measure
Subtle biomechanical signals and interstitial fluid with key biomarkers. [ Time Frame: From enrollment to end of study period at 8 days. ]
Central Contacts
- Kyla Shea, PhD16175563370
- Emilie Buisson, MS
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Jean Mayer USDA Human Nutrition Research Center on Aging | Boston | Massachusetts | 02111 | - |
Find similar trials in Boston, MA
Related Studies
- Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related ConditionsRecruiting · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · Bethesda, Maryland
- Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2PHASE2 · Enrolling By Invitation · National Institute of Neurological Disorders and Stroke (NINDS) · Bethesda, Maryland
- Confirmatory Efficacy of the Building a Strong Identity and Coping Skills ProgramRecruiting · Penn State University · Harrisburg, Pennsylvania
- Effects of Oral Supplement Containing L-Histidine and Antioxidants on the Skin Barrier Function and Systemic Inflammation in RosaceaRecruiting · Integrative Skin Science and Research · Sacramento, California